Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Aventis Pharma SA Antony FR
01 1N-Tallow-1,3-propylenediamine, For the manufacture of an antistatic additive to solvents
01 1France
01 1Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
N-Tallow-1,3-propylenediamine, For The Manufactu...
Certificate Number : R1-CEP 2001-017 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2006-04-18
Type : TSE
Substance Number :
20
Aventis Pharma Sa Antony Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is N-Tallow-1,3-propylenediamine, For the manufacture of an antistatic additive to solvents, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-017 - Rev 00
This TSE Type CEP, issued on April 18, 2006, remains in force until August 01, 2011, ensuring its reliability within the pharmaceutical industry.
